Surgical Preparation: The SHARP Method
Surgery without preparation is incomplete medicine. The standard preoperative workup — basic labs, medical clearance, a list of medications to stop — was designed to answer one question: Can this patient survive surgery? It does not ask whether your body is ready to heal from it. The SHARP Method asks that question, and builds the answer before the first incision is ever made.
What Standard Surgical Preparation Misses
Most preoperative protocols identify contraindications. They do not optimize biology. Research published in Burns & Trauma (Oxford Academic) shows that 20–45% of surgical patients demonstrate signs of protein-energy malnutrition before surgery — and those patients experience measurably higher rates of infection, delayed wound healing, and longer hospital stays. The hidden variables — genetics, toxin burden, microbiome, sensitivities, hormones — are never assessed at all.
| What Gets Assessed | Standard Prep | ERAS Protocol | SHARP Preparation |
|---|---|---|---|
| Basic labs and medical history | ✓ | ✓ | ✓ |
| Primary care clearance | ✓ | ✓ | ✓ |
| Perioperative medication management | — | ✓ | ✓ |
| Genetic detoxification capacity | — | — | ✓ |
| Environmental and mycotoxin burden | — | — | ✓ |
| Gut microbiome health | — | — | ✓ |
| Food sensitivity and inflammatory burden | — | — | ✓ |
| Hormonal balance | — | — | ✓ |
| Personalized supplementation protocol | — | — | ✓ |
The Six Pillars of Surgical Preparation
The SHARP Method addresses six specific biological systems that directly influence surgical outcomes. Each is assessed individually; the findings inform a preparation protocol built for your biology.
Genetic Detoxification Profiling
The MTHFR gene encodes an enzyme critical for folate processing, DNA synthesis, and detoxification. MTHFR C677T and A1298C polymorphisms reduce enzyme activity — published research demonstrates that patients carrying these mutations who receive nitrous oxide anesthesia experience significantly elevated postoperative homocysteine levels. Understanding detoxification genetics before surgery directly informs safe anesthetic management.
- •MTHFR C677T and A1298C polymorphisms
- •Phase 1 detoxification enzyme variants (CYP450 pathways)
- •Phase 2 conjugation pathway capacity
- •Phase 3 transporter gene variants
Toxic Burden Assessment
87 toxins assessed across three categories: environmental chemicals (38), mycotoxins (29), and heavy metals (20). Toxic burden elevates baseline inflammation and suppresses immune function — the two systems surgery stresses most. For explant patients: platinum and other heavy metals have been documented in capsule tissue analysis.
- •PFAS compounds, BPA, glyphosate, phthalates
- •Aflatoxins, fumonisins, ochratoxin A, trichothecenes
- •Mercury, lead, arsenic, cadmium, platinum, cesium
Gut Microbiome Analysis (PCR-Based)
A literature review published in PMC (2025) found that properly timed probiotic and synbiotic supplementation before surgery can reduce surgical site infection risk by 40–80%, help patients recover bowel function 1–2 days faster, and reduce hospital stays by up to 30%. Dr. Whitfield uses PCR-based analysis to identify specific imbalances.
- •Microbial diversity and balance scores
- •Pathogen overgrowth (bacterial, fungal, parasitic)
- •Short-chain fatty acid producing species
- •Inflammatory microbiome markers
Food Sensitivity Testing
200+ foods tested for IgG-mediated sensitivities and inflammatory triggers. Chronic subclinical inflammation from hidden food sensitivities elevates CRP, IL-6, and other pro-inflammatory markers — creating an elevated inflammatory baseline before surgery even begins.
- •IgG-mediated sensitivity panel (200+ foods)
- •Inflammatory trigger identification
- •Elimination protocol during preparation period
Hormonal Balance Assessment
Hormones govern wound healing, tissue regeneration, and immune modulation. For BII patients, hormonal disruption is one of the most commonly reported presenting symptoms. The preparation protocol addresses this as a biological prerequisite for safe and efficient recovery.
- •Cortisol — elevated levels suppress immune function
- •Thyroid (T3/T4/TSH) — insufficiency slows healing rate
- •Estrogen / Progesterone — regulate collagen synthesis
- •Testosterone — supports tissue regeneration
- •Vitamin D — deficiency increases post-surgical infection risk
Personalized Supplementation
The findings from all five preceding assessments inform a supplementation protocol built specifically for each patient's biology. Supplements are not discontinued before surgery — Dr. Whitfield maintains patients on the SHARP protocol through the perioperative period. Dosing is based on documented deficiencies, not population averages.
- •Targeted to documented deficiencies
- •Interactions with anesthesia assessed and managed
- •No outside proprietary blends permitted
- •Maintained through surgery (not stopped)
Supplements Are Not Stopped Before Surgery
Standard surgical practice instructs patients to stop all supplements two to four weeks before surgery — a blanket policy designed to manage bleeding risk from fish oil, vitamin E, and herbal agents.
Dr. Whitfield's approach is different: patients continue the SHARP supplement protocol through surgery. These formulations are specifically designed to support detoxification and immune function during exactly the kind of biological stress surgery creates. Removing them in the weeks before surgery withdraws support at the moment it is most needed.
Outside supplements — proprietary blends with unknown antioxidant loads, unregulated herbal compounds, or agents with unclear coagulation effects — are not permitted during the perioperative period. The protocol is managed, not generic.
“What I've seen over 1,000+ explant procedures is that the patients who recover fastest and feel best are the ones who arrived prepared. The surgery is the same. The recovery is not.”
Why Preparation Determines Recovery
The research is consistent: the biological state a patient is in at the time of surgery shapes the recovery they will have.
| Biological Variable | Impact on Surgical Outcomes |
|---|---|
| Protein-energy malnutrition (present in 20–45% of surgical patients) | Higher infection rates, delayed wound healing, longer hospital stays |
| Gut microbiome optimization | 40–80% reduction in surgical site infection risk; 30% shorter hospital stay |
| Sleep deprivation (≥1 night) | Delays wound healing by approximately one full day; blunts local cytokine response |
| MTHFR mutation with N₂O anesthesia exposure | Elevated postoperative homocysteine; documented neurological risk |
| Elevated inflammatory baseline | Extended post-surgical inflammatory phase; increased complication risk |
Who This Is For
| Patient Profile | Why Preparation Matters |
|---|---|
| Breast implant removal (explant) | Years of immune activation, toxic burden, and hormonal disruption require direct pre-surgical intervention |
| Revision surgery | Factors contributing to prior complications can be identified and corrected before the second procedure |
| Autoimmune conditions | Immune optimization before surgery reduces flare risk and supports healing |
| Health-conscious surgical patients | Patients who already invest in their health want the same standard applied to surgical preparation |
| Complex medical histories | Multiple medications, chronic illness, and prior complications require deeper biological assessment |
| Patients seeking a second opinion | A preparation assessment often identifies what a prior surgical plan missed |
SHARP Preparation Program Tiers
Foundational
$3,875
Core six-pillar assessment, personalized supplement protocol, preparation guidance
Get StartedPremium
$8,000
Expanded testing panels, direct clinical team access, full protocol management
Get StartedConcierge
$11,325
White-glove preparation — all assessments, all protocols, dedicated coordination through surgery
Get StartedAll three tiers include the full six-pillar framework. The difference is depth of testing, level of clinical access, and degree of hands-on protocol management.
Dr. Robert Whitfield’s Credentials
- Board-Certified Plastic Surgeon, FACS — American Board of Plastic Surgery
- 1,000+ explant procedures — Among the highest-volume explant practices nationally
- Published researcher — First author, largest PCR-tested explant capsule series (Microorganisms, 2024, PMID 39338504); published on fat grafting safety (Aesthetic Surgery Journal, 2017, PMID 29044365)
- FDA witness — Testified before the General and Plastic Surgery Devices Panel on breast implant safety
- Past President — Aesthetic Surgery Education and Research Foundation (ASERF)
- Author — The SHARP Method and Breast Implants, Explant Surgery and Breast Implant Illness
Frequently Asked Questions About SHARP Preparation
Do I have to be Dr. Whitfield's surgical patient to enroll in the preparation program?
+
No. The SHARP preparation protocol is available to patients preparing for surgery with any surgeon. Findings can be shared with your surgical team.
When should I begin preparation?
+
The earlier you begin, the more time the protocol has to address identified imbalances. This is discussed during your discovery call based on your specific surgery date.
Is this a replacement for my surgeon's preoperative instructions?
+
No — it is additive. All standard preoperative instructions from your surgical team remain in effect. The SHARP protocol addresses biological optimization that standard preoperative protocols do not assess.
What happens after surgery?
+
The protocol transitions into the SHARP recovery phase. Learn about the SHARP Recovery Protocol at /sharp/recovery.
Is the program available virtually?
+
Yes. All assessment kits are shipped directly to you. Consultations are conducted virtually. Patients from 40+ states and 15 countries have enrolled.
References
- Whitfield R, Tipton CD, Diaz N, Ancira J, Landry KS. “Clinical Evaluation of Microbial Communities and Associated Biofilms with Breast Augmentation Failure.” Microorganisms. 2024. PMID: 39338504.
- Whitfield R et al. Fat grafting safety. Aesthetic Surgery Journal. 2017. PMID: 29044365.
- “Timing and Protocols for Microbiome Intervention in Surgical Patients: A Literature Review of Current Evidence.” PMC. 2025. PMC12264445.
- “Influence of Methylenetetrahydrofolate Reductase Gene Polymorphisms on Homocysteine Concentrations after Nitrous Oxide Anesthesia.” ResearchGate. PMID referenced at PMC4546078.
- “Misconceptions about Protein Requirements for Wound Healing: Results of a Prospective Study.” HMP Global Learning Network.
- ESPEN Guidelines on Perioperative Nutrition. Protein recommendations: 1.2–2.0 g/kg/day perioperatively.
- Enhanced Recovery After Surgery (ERAS) Society. ERAS Guidelines. erassociety.org.
Related Resources
The SHARP Method
Overview of the 3-phase protocol
SHARP Biohacking Stack
Evidence-based recovery technology
SHARP Recovery Protocol
Post-operative recovery protocol
Explant Surgery
Complete breast implant removal
Functional Medicine
Root-cause health optimization
Published Research
Peer-reviewed publications
yoursurgicalrecovery.com
Full recovery resource
mysharpmethod.com
Full SHARP Method detail
You Deserve a Surgeon Who Prepares You, Not Just Operates on You.
Dr. Robert Whitfield has guided thousands of patients through surgical decisions with clarity, data, and a personalized plan. Your consultation is where that plan begins.
Not ready to book? Download the free Inflammation Support Guide to start your journey.